Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Medical composition for treating climacteric syndrome and preparation thereof

A composition and syndrome technology, applied in the direction of drug combination, pharmaceutical formulation, drug delivery, etc., can solve problems such as allergies, ointment overflow, skin irritation, etc., and achieve broad application prospects, improved effects, and high safety effects

Inactive Publication Date: 2016-06-15
ZHEJIANG STRONG PHARMA CO LTD
View PDF2 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] At present, there are still many shortcomings in sex hormone replacement therapy, such as increasing the burden on the liver, increasing the incidence of endometrial cancer, breast cancer, thrombotic disease, and cholelithiasis, etc., causing certain risks to women receiving treatment
There are many deficiencies in the external hormone paste that is used now on the market, as because the plaster preparation is to take the package therapy skin ulceration and allergies are not uncommon; the rubber plaster has poor air permeability, irritation to the skin, and the shortcoming of being prone to allergies; The curing time of the plaster is not easy to control, the adhesion is poor, and the paste overflows, etc.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medical composition for treating climacteric syndrome and preparation thereof
  • Medical composition for treating climacteric syndrome and preparation thereof
  • Medical composition for treating climacteric syndrome and preparation thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0024] A pharmaceutical composition for treating menopausal syndrome, in terms of the following weight ratio, each component and its content are: 1 part of cassia twig, 0.5 part of dried ginger, 2 parts of schisandra, 2 parts of inula, 3.5 parts of bamboo leaves, 2 parts of peony bark, 0.5 part of jujube, 2 parts of fried jujube kernel, 2 parts of dogwood, 2 parts of raw land, 2 parts of Codonopsis pilosula, 0.5 part of gardenia. The pharmaceutical composition for treating menopausal syndrome is made into pills.

[0025] The preparation method of the pharmaceutical composition for the treatment of climacteric syndrome described above, is characterized in that: comprise the following steps,

[0026] A. The above sixteen herbs are decocted with water, the quality of the water added is 7-10 times the mass of the sixteen herbs, decocted 3 times, the first decoction is 1.5h, the second decoction is 1h, and the third decoction Cook for 0.5h;

[0027] B. merge the filtrate obtained...

Embodiment 2

[0030] A pharmaceutical composition for treating menopausal syndrome, in terms of the following weight ratio, each component and content are: 3 parts of cassia twig, 2 parts of dried ginger, 4 parts of Schisandra chinensis, 4 parts of Inula inula, 5 parts of Bamboo leaves, 4 parts of peony bark, 2 parts of jujube, 4 parts of fried jujube kernel, 4 parts of dogwood, 4 parts of raw land, 4 parts of Codonopsis pilosula, 2 parts of gardenia. The pharmaceutical composition for treating climacteric syndrome is made into an oral liquid.

[0031] The preparation method of the pharmaceutical composition for the treatment of climacteric syndrome described above, is characterized in that: comprise the following steps,

[0032] A. The above sixteen medicinal materials are decocted with water, the quality of the water added is 10 times the mass of the sixteen medicinal materials, decocted 3 times, the first decoction is 3 hours, the second decoction is 2 hours, and the third decoction is 1...

Embodiment 3

[0036]A pharmaceutical composition for treating menopausal syndrome, in terms of the following weight ratio, each component and its content are: 2.5 parts of cassia twig, 1.5 parts of dried ginger, 3.5 parts of Schisandra chinensis, 3.5 parts of Inula inula, 4.8 parts of bamboo leaves, 3.5 parts of peony bark, 1.5 parts of jujube, 3.5 parts of fried jujube kernel, 3.5 parts of dogwood, 3.5 parts of raw land, 3.5 parts of Codonopsis pilosula, 1.5 parts of gardenia. The pharmaceutical composition for treating menopausal syndrome is made into tablets.

[0037] The preparation method of the pharmaceutical composition for the treatment of climacteric syndrome described above, is characterized in that: comprise the following steps,

[0038] A. The above sixteen medicinal materials are decocted with water, the quality of the water added is 8 times the mass of the sixteen medicinal materials, decocted 3 times, the first decoction is 2 hours, the second decoction is 1.5 hours, and the ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to Chinese herbal compound treatment and discloses a medical composition for treating climacteric syndrome. The medical composition comprises the following components and contents in parts by weight: 1-3 parts of cassia twigs, 0.5-2 parts of Rhizoma Zingiberis, 2-4 parts of fructus schizandrae, 2-4 parts of Inula japonica, 3.5-5 parts of Lophatherum gracile, 2-4 parts of cortex moutan radicis, 0.5-2 parts of Chinese Date, 2-4 parts of Fried jujube, 2-4 parts of Cornus officinalis, 2-4 parts of Rhizome of rehmannia, 2-4 parts of Codonopsis pilosul, and 0.5-2cape jasmine. By means of the synergistic effect of the sixteen ingredients, the medical composition has following beneficial effects: tonifying liver and qi, nourishing blood and tranquilization, clearing deficient heat and relieving restlessness. The invention also discloses a preparation method for the medical composition for treating climacteric syndrome. The method is convenient; preparation condition is simple; the method is safe and reliable which is suitable for industrial production.

Description

technical field [0001] The invention relates to a traditional Chinese medicine compound treatment agent, relates to a pharmaceutical composition for treating climacteric syndrome, in particular to a preparation method of the pharmaceutical composition for treating climacteric syndrome. Background technique [0002] Menopausal syndrome is a series of symptoms caused by a drop in estrogen levels. A small number of women have obvious symptoms because the body cannot adapt quickly, but generally do not need special treatment. Very few symptoms are severe, and even affect life and work, you need to use Chinese medicine Yishen Gengniankang for treatment. It is generally believed that after women enter menopause, changes in their family and social environment can increase their physical and mental burdens, making menopausal syndrome prone to occur or aggravating certain existing symptoms. Some women with unstable mental state themselves have more obvious menopausal syndrome, even...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/9068A61P15/12
CPCA61K9/4866A61K36/28A61K36/344A61K36/40A61K36/54A61K36/57A61K36/71A61K36/725A61K36/744A61K36/79A61K36/804A61K36/899A61K36/9068A61K2236/331A61K2236/39A61K2236/53A61K2236/51A61K2300/00A61K36/185A61K36/65A61P15/12A61P5/24A61K9/08A61K9/14A61K9/20A61K9/48
Inventor 虞陆平
Owner ZHEJIANG STRONG PHARMA CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products